Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
-4.31%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$43.7B
AUM Growth
+$158M
(+0.36%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
2.67%
Top 10 Holdings %
Top 10 Hldgs %
11.64%
Holding
4,109
New
199
Increased
895
Reduced
1,260
Closed
190
Top Buys
| 1 |
Hewlett Packard
HPE
|
$488M |
| 2 |
Halliburton
HAL
|
$458M |
| 3 |
Archer Daniels Midland
ADM
|
$456M |
| 4 |
Gen Digital
GEN
|
$413M |
| 5 |
WESCO International
WCC
|
$251M |
Top Sells
| 1 |
Vistra
VST
|
$614M |
| 2 |
Exxon Mobil
XOM
|
$498M |
| 3 |
Chevron
CVX
|
$435M |
| 4 |
Occidental Petroleum
OXY
|
$432M |
| 5 |
Cisco
CSCO
|
$411M |
Sector Composition
| 1 | Consumer Discretionary | 17.28% |
| 2 | Technology | 17.14% |
| 3 | Energy | 14.05% |
| 4 | Industrials | 10.98% |
| 5 | Healthcare | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Carvana
CVNA
$50.9B
| $40.3K | ﹤0.01% |
313
-337
| -52% | -$43.4K |
|
1277
Protolabs
PRLB
$1.19B
| $39.5K | ﹤0.01% |
1,278
+234
| +22% | +$7.23K |
|
1278
BridgeBio Pharma
BBIO
$10.2B
| $39.1K | ﹤0.01% |
1,545
+72
| +5% | +$1.82K |
|
1279
Biohaven
BHVN
$1.68B
| $38.6K | ﹤0.01% |
1,113
+376
| +51% | +$13.1K |
|
1280
Stratasys
SSYS
$871M
| $37.2K | ﹤0.01% |
4,433
+1,195
| +37% | +$10K |
|
1281
Amphastar Pharmaceuticals
AMPH
$1.37B
| $37.1K | ﹤0.01% |
927
+135
| +17% | +$5.4K |
|
1282
Cable One
CABO
$922M
| $35.4K | ﹤0.01% |
100
-569
| -85% | -$201K |
|
1283
CONMED
CNMD
$1.7B
| $34.8K | ﹤0.01% |
+502
| New | +$34.8K |
|
1284
Rapid7
RPD
$1.32B
| $34.7K | ﹤0.01% |
802
-186
| -19% | -$8.04K |
|
1285
TG Therapeutics
TGTX
$5.11B
| $34.1K | ﹤0.01% |
1,917
-625
| -25% | -$11.1K |
|
|
SWTX
1286
DELISTED
SpringWorks Therapeutics
SWTX
| $33.4K | ﹤0.01% |
887
+53
| +6% | +$2K |
|
1287
Iovance Biotherapeutics
IOVA
$901M
| $30.7K | ﹤0.01% |
3,831
+1,115
| +41% | +$8.94K |
|
1288
Ambarella
AMBA
$3.54B
| $30.2K | ﹤0.01% |
560
-104
| -16% | -$5.61K |
|
1289
Global E Online
GLBE
$6.07B
| $30K | ﹤0.01% |
826
-40
| -5% | -$1.45K |
|
1290
Calix
CALX
$3.96B
| $29.9K | ﹤0.01% |
843
-207
| -20% | -$7.33K |
|
1291
NetEase
NTES
$85B
| $29.6K | ﹤0.01% |
310
+13
| +4% | +$1.24K |
|
1292
DoubleVerify
DV
$2.45B
| $29.6K | ﹤0.01% |
1,520
+276
| +22% | +$5.37K |
|
1293
Ultragenyx Pharmaceutical
RARE
$3.07B
| $29.5K | ﹤0.01% |
718
-122
| -15% | -$5.01K |
|
1294
Dyne Therapeutics
DYN
$2.02B
| $29.2K | ﹤0.01% |
827
-773
| -48% | -$27.3K |
|
1295
Twist Bioscience
TWST
$1.55B
| $28.9K | ﹤0.01% |
586
-552
| -49% | -$27.2K |
|
1296
Crinetics Pharmaceuticals
CRNX
$3.35B
| $28.6K | ﹤0.01% |
638
-373
| -37% | -$16.7K |
|
1297
Acadia Pharmaceuticals
ACAD
$4.26B
| $28.2K | ﹤0.01% |
1,735
-87
| -5% | -$1.41K |
|
1298
Nuvalent
NUVL
$5.83B
| $27.9K | ﹤0.01% |
368
-133
| -27% | -$10.1K |
|
1299
3D Systems Corporation
DDD
$272M
| $27.4K | ﹤0.01% |
8,924
+2,662
| +43% | +$8.17K |
|
1300
Ardelyx
ARDX
$1.57B
| $27.1K | ﹤0.01% |
3,656
-1,253
| -26% | -$9.29K |
|